WESTFORD, Mass., Oct. 13, 2011 /PRNewswire/ -- Cynosure, Inc.
(Nasdaq: CYNO), a leading developer and manufacturer of a broad
array of light-based aesthetic treatment systems, today announced
that the company will release its third-quarter 2011 financial
results before the market opens on Tuesday,
October 25 and host a conference call for investors and
analysts that day at 9:00 a.m.
ET.
On the call, President and Chief Executive Officer Michael Davin and Executive Vice President and
Chief Financial Officer Timothy
Baker will discuss Cynosure's financial results, as well as
the company's business outlook and strategy.
Those who wish to listen to the conference call webcast should
visit the "Investor Relations" section of the company's website at
www.cynosure.com. The live call also can be accessed by
dialing (877) 407-5790 or (201) 689-8328. If you are unable
to listen to the live call, the webcast will be archived on the
company's website.
About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems
that are used by physicians and other practitioners to perform
non-invasive and minimally invasive procedures to remove hair,
treat vascular and pigmented lesions, rejuvenate the skin, liquefy
and remove unwanted fat through laser lipolysis, reduce the
appearance of cellulite and treat onychomycosis. Cynosure's
products include a broad range of laser and other light-based
energy sources, including Alexandrite, pulse dye, Q-switched,
Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure
was founded in 1991. For corporate or product information,
contact Cynosure at 800-886-2966, or visit www.cynosure.com.
Contact
Scott Solomon
Vice President
Sharon Merrill Associates, Inc.
617-542-5300
cyno@investorrelations.com
SOURCE Cynosure, Inc.